Building on the success of TRX09, TRX10 aims to set new standards for the region in stimulating trans-disciplinary collaborations across all areas of human disease research, drug and diagnostic discovery and development, IT and bioinformatics.
Managers and scientists in medical research institutes, universities and bio-pharmaceutical companies have witnessed an explosive development in the application of powerful computing, laboratory automation, and molecular sciences. The world over, the convergence of these disciplines brings about a fundamental shift in the way medical research, drug research and, ultimately, patient care is undertaken. This shift also impacts academia, industry and governments.
Pharmacogenomics, toxicogenomics, visualisation of disease mechanisms and many other innovative disciplines and technologies all produce an incredible amount of data that then needs to be managed, analysed and interpreted in a relevant biological and medical context which is made possible by bioinformatics - the application of information technology, statistics and mathematics to biological and medical problems involving large volumes of data with complex inter-relationships.
In order to create an international awareness focussed on the Asia-Pacific Region’s current translational biomedical research, IT and bioinformatics capabilities, TRX10 brings together these diverse yet related disciplines and stakeholders in the relaxed subtropical surroundings of Brisbane in Queensland, and provides a platform where delegates can share issues and best practices related to translational research, policy-making, enabling technologies and bioinformatics.
Overseas visitors will also benefit from the fact that TRX10 is surrounded by a number of satellite events, including the 5th Annual Investment Forum.
I look forward to welcoming you to sunny Queensland – the Smart State - in October 2010.
Mario Pennisi
Chief Executive Officer
Queensland Clinical Trials Network Inc. (QCTN)